{"id":"nicotine-polacrilex-gum-2-mg","safety":{"commonSideEffects":[{"rate":null,"effect":"Mouth and throat irritation"},{"rate":null,"effect":"Hiccups"},{"rate":null,"effect":"Dyspepsia"},{"rate":null,"effect":"Jaw soreness"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":{"setId":"826f0ce5-9862-4f6f-8943-a3f06b07e69f","title":"HABITROL NICOTINE POLACRILEX GUM 2 MG COATED MINT (NICOTINE POLACRILEX) GUM, CHEWING [DR. REDDY'S LABORATORIES INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Nicotine polacrilex is a nicotine replacement therapy in which nicotine is bound to an ion-exchange resin (polacrilex) and delivered via chewing gum. When chewed, nicotine is released and absorbed through the oral mucosa, binding to nicotinic acetylcholine receptors throughout the central and peripheral nervous system. This activation mimics the effects of smoking without the harmful combustion byproducts, thereby reducing withdrawal symptoms and cravings that occur during smoking cessation attempts.","oneSentence":"Nicotine binds to nicotinic acetylcholine receptors in the brain to reduce cravings and withdrawal symptoms during smoking cessation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T05:18:39.522Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Smoking cessation aid"},{"name":"Reduction of nicotine withdrawal symptoms"}]},"trialDetails":[{"nctId":"NCT06356610","phase":"NA","title":"Pharmacokinetic and Subjective Effects of Heated Tobacco Products","status":"COMPLETED","sponsor":"Altria Client Services LLC","startDate":"2024-02-06","conditions":"Tobacco Use","enrollment":80},{"nctId":"NCT05515354","phase":"PHASE4","title":"Smoking Cessation and Menstrual Cycle Phase","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2022-11-30","conditions":"Nicotine Dependence, Tobacco Smoking, Smoking Cessation","enrollment":1200},{"nctId":"NCT06966362","phase":"PHASE4","title":"Varenicline for Smoking Reduction in Veterans Not Ready To Quit","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-07-01","conditions":"Veterans, Tobacco Use Disorder, Cigarette Smoking","enrollment":400},{"nctId":"NCT06554873","phase":"PHASE3","title":"Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders","status":"COMPLETED","sponsor":"Rose Research Center, LLC","startDate":"2024-08-29","conditions":"Smoking Cessation, Harm Reduction","enrollment":150},{"nctId":"NCT04634071","phase":"PHASE2","title":"Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment","status":"COMPLETED","sponsor":"Joseph Valentino, MD","startDate":"2021-01-12","conditions":"Smoking Cessation, Cancer, Treatment-Related","enrollment":126},{"nctId":"NCT07132814","phase":"NA","title":"Abuse Liability for Five Modern Oral Nicotine Products","status":"RECRUITING","sponsor":"RAI Services Company","startDate":"2025-12-15","conditions":"Smoking, Smoking Behaviors, Tobacco Use","enrollment":40},{"nctId":"NCT07254832","phase":"NA","title":"Effects of Caffeine and Nicotine Gum on Balance Performance in Athletes","status":"COMPLETED","sponsor":"Gülbin Rudarlı","startDate":"2024-01-08","conditions":"Athletic Performance, Postural Stability, Healhty","enrollment":20},{"nctId":"NCT07075575","phase":"NA","title":"Quit-Smoking Study for Native Hawaiians","status":"RECRUITING","sponsor":"University of Hawaii","startDate":"2025-11-01","conditions":"Tobacco Use Disorder, Smoking Cessation","enrollment":75},{"nctId":"NCT04199117","phase":"PHASE4","title":"Health Systems Reach Interventions Project","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2020-03-11","conditions":"Smoking, Cigarette, Smoking Cessation","enrollment":210},{"nctId":"NCT06098144","phase":"PHASE4","title":"Smoking Cessation Program in the Construction Sector","status":"RECRUITING","sponsor":"University of Miami","startDate":"2024-04-10","conditions":"Smoking Cessation, Tobacco Use Cessation, Tobacco Smoking","enrollment":608},{"nctId":"NCT05154669","phase":"PHASE3","title":"Integrating Financial Coaching and Smoking Cessation Coaching","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2022-12-08","conditions":"Smoking","enrollment":488},{"nctId":"NCT05683821","phase":"NA","title":"BREATHE 2 Clinic Stop-Smoking Treatment Outreach Study","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2023-07-24","conditions":"Quitting Smoking, Smoking Cessation, Smoking, Cigarette","enrollment":12376},{"nctId":"NCT06931054","phase":"NA","title":"Combination of Acupuncture, Auricular Acupressure and Nicotine Replacement Therapy for Smoking Cessation","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-05-05","conditions":"Smoking","enrollment":270},{"nctId":"NCT05257629","phase":"PHASE3","title":"Aggressive Smoking Cessation Trial (ASAP)","status":"RECRUITING","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2023-02-02","conditions":"Acute Coronary Syndrome, Cardiovascular Diseases","enrollment":798},{"nctId":"NCT01959607","phase":"NA","title":"Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)","status":"COMPLETED","sponsor":"Philip Morris Products S.A.","startDate":"2013-07","conditions":"Smoking","enrollment":65},{"nctId":"NCT06171490","phase":"NA","title":"Pharmacokinetics and Comparative Bioavailability of Nicotine From Two Variants of NP2, NP2-4mg and NP2-6mg, Compared to Nicotine Lozenge 4mg (Loz-4mg) and Nicotine Gum 4mg (Gum-4mg)","status":"COMPLETED","sponsor":"Philip Morris Products S.A.","startDate":"2023-10-20","conditions":"Tobacco Use","enrollment":56},{"nctId":"NCT05290025","phase":"NA","title":"Easy Access to Smoking Cessation for People Receiving Opioid Agonist Therapy Who Are Smoking Tobacco","status":"ACTIVE_NOT_RECRUITING","sponsor":"Haukeland University Hospital","startDate":"2022-04-07","conditions":"Smoking Cessation, Substance-Related Disorders","enrollment":266},{"nctId":"NCT04384562","phase":"NA","title":"Studying the Role of Brain Molecules for Decision Making","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2020-12-17","conditions":"Decision Making, Healthy","enrollment":160},{"nctId":"NCT06063421","phase":"NA","title":"Comparison of Nicotine Replacement Therapy and Electronic Cigarettes for Smoking Cessation in Pakistan","status":"NOT_YET_RECRUITING","sponsor":"Strategic Health Research Limited","startDate":"2024-06-01","conditions":"Smoking Cessation, Electronic Cigarette Use","enrollment":438},{"nctId":"NCT01935713","phase":"NA","title":"Preliminary Investigation of Novel Methods to Reduce Children's Secondhand Smoke Exposure","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2012-04","conditions":"Secondhand Smoke","enrollment":89},{"nctId":"NCT05157672","phase":"EARLY_PHASE1","title":"Evaluating the Pharmacokinetics and Drug Interaction Potential of the Botanical Dietary Supplement Cinnamon","status":"UNKNOWN","sponsor":"Washington State University","startDate":"2021-12-14","conditions":"Interaction Drug Food","enrollment":16},{"nctId":"NCT05060965","phase":"EARLY_PHASE1","title":"Inpatient Smoking Cessation Pilot Program","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2019-10-01","conditions":"Tobacco Use Cessation","enrollment":""},{"nctId":"NCT04717544","phase":"NA","title":"Embedding Comprehensive Smoking Cessation Programs Into Community Clinics","status":"COMPLETED","sponsor":"Friends Research Institute, Inc.","startDate":"2019-10-01","conditions":"Smoking Cessation","enrollment":406},{"nctId":"NCT05484505","phase":"EARLY_PHASE1","title":"Preloaded Combination Nicotine Replacement Therapy on Smoking Cessation of Adult Population in Kazakhstan","status":"UNKNOWN","sponsor":"Nazarbayev University","startDate":"2023-07-01","conditions":"Smoking Cessation, Smoking, Cigarette, Smoking Behaviors","enrollment":200},{"nctId":"NCT04461288","phase":"NA","title":"Engaging Sexual and Gender Minority Cigarette Smokers Into Social Media-based Treatment","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2020-05-01","conditions":"Smoking Cessation, Nicotine Dependence, Tobacco Use","enrollment":121},{"nctId":"NCT01964807","phase":"NA","title":"Cardiovascular Assessment of the Effects of Tobacco and Nicotine Delivery Products","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2013-11-03","conditions":"Adverse Effect of Other Agents Primarily Affecting the Cardiovascular System, Initial Encounter","enrollment":81},{"nctId":"NCT00064844","phase":"PHASE4","title":"Combination Nicotine Replacement for Alcoholic Smokers","status":"COMPLETED","sponsor":"Yale University","startDate":"2002-08","conditions":"Smoking, Alcoholism","enrollment":96},{"nctId":"NCT02995915","phase":"PHASE4","title":"Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking","status":"COMPLETED","sponsor":"Duke University","startDate":"2016-11","conditions":"Smoking Cessation, Alcohol Drinking","enrollment":45},{"nctId":"NCT00701896","phase":"NA","title":"Smoking Cessation Using Motivational Therapy and Varenicline","status":"COMPLETED","sponsor":"Philip Diaz","startDate":"2008-10-03","conditions":"Smoking, HIV Infections","enrollment":294},{"nctId":"NCT04372290","phase":"NA","title":"CSD190401: A Study to Assess Elements of Abuse Liability for Nicotine-containing Pouch Tobacco Products","status":"COMPLETED","sponsor":"RAI Services Company","startDate":"2020-05-06","conditions":"Smoking, Smoking Behaviors, Tobacco Use","enrollment":42},{"nctId":"NCT04501016","phase":"PHASE2, PHASE3","title":"A Stepped Care Approach to Treating Tobacco Use in Rural Veterans","status":"NOT_YET_RECRUITING","sponsor":"Iowa City Veterans Affairs Medical Center","startDate":"2020-09","conditions":"Tobacco Cessation","enrollment":100},{"nctId":"NCT02168855","phase":"NA","title":"Cessation in Non-Daily Smokers","status":"COMPLETED","sponsor":"Brian Primack","startDate":"2015-06","conditions":"Smoking","enrollment":505},{"nctId":"NCT02307045","phase":"PHASE4","title":"Effect of Smoking Reduction on Endothelial Glucocalyx and Vascular Function","status":"UNKNOWN","sponsor":"University of Athens","startDate":"2014-12-03","conditions":"Smoking Cessation","enrollment":600},{"nctId":"NCT01967706","phase":"NA","title":"Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol).","status":"COMPLETED","sponsor":"Philip Morris Products S.A.","startDate":"2013-08","conditions":"Smoking","enrollment":73},{"nctId":"NCT00469079","phase":"PHASE2","title":"Health Effects of SLT, Cigarette Smoking, and New Tobacco Products","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2007-01","conditions":"Nicotine Dependence","enrollment":130},{"nctId":"NCT02420015","phase":"PHASE4","title":"Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia","status":"COMPLETED","sponsor":"Duke University","startDate":"2017-03-27","conditions":"Schizophrenia, Cigarette Smoking","enrollment":35},{"nctId":"NCT03259607","phase":"PHASE1","title":"Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and Nicorette® Mint Gum in Healthy Smokers","status":"COMPLETED","sponsor":"McNeil AB","startDate":"2017-08-14","conditions":"Tobacco Dependence","enrollment":76},{"nctId":"NCT02873754","phase":"NA","title":"Smoking Treatment and Exercise Program for Underserved Populations (STEP UP)","status":"COMPLETED","sponsor":"Duke University","startDate":"2017-01","conditions":"Smoking","enrollment":11},{"nctId":"NCT02664012","phase":"NA","title":"Comparison of Nicotine Plasma Concentrations and Subjective Effects for Three Menthol Electronic Cigarettes vs Combustible Menthol Cigarettes and Nicotine Gum","status":"COMPLETED","sponsor":"R.J. Reynolds Vapor Company","startDate":"2016-01","conditions":"Smoking","enrollment":71},{"nctId":"NCT02269514","phase":"NA","title":"Comparison of Nicotine Plasma Concentrations and Subjective Effects for Three Electronic Cigarettes vs Combustible Cigarettes and Nicotine Gum","status":"COMPLETED","sponsor":"R.J. Reynolds Vapor Company","startDate":"2014-05","conditions":"Smoking","enrollment":45},{"nctId":"NCT02323438","phase":"NA","title":"Assess Biomarkers of Tobacco Exposure and Nicotine Pharmacokinetics in Smokers After a 5-Day In-Clinic Confinement Switch to an Electronic Cigarette or Nicotine Gum","status":"COMPLETED","sponsor":"R.J. Reynolds Vapor Company","startDate":"2014-12","conditions":"Smoking","enrollment":153},{"nctId":"NCT02354638","phase":"NA","title":"Impact of Smoke Free Public Places (Smoke Free Cabs) on Cab Drivers in Mumbai","status":"COMPLETED","sponsor":"Tata Memorial Hospital","startDate":"2014-12","conditions":"Compliance","enrollment":400},{"nctId":"NCT02397369","phase":"NA","title":"Evaluation of Efficacy of Different Methods of Tobacco Cessation Interventions Among BEST Employees in Mumbai","status":"UNKNOWN","sponsor":"Tata Memorial Hospital","startDate":"2015-03","conditions":"Compliance, Tobacco Use Cessation","enrollment":4000},{"nctId":"NCT02688374","phase":"PHASE1","title":"A Bioequivalence Study of Three, 2 mg Nicotine Chewing Gums (Two Tests and One Reference) in Healthy Adult Smokers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-03-11","conditions":"Tobacco Use Disorder","enrollment":45},{"nctId":"NCT00710034","phase":"PHASE2","title":"Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2010-04","conditions":"Tobacco Use Disorder","enrollment":391},{"nctId":"NCT01989923","phase":"NA","title":"Smoking Cessation in Women With Gynecological Conditions","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2013-06","conditions":"Cervical Dysplasia","enrollment":31},{"nctId":"NCT01623505","phase":"PHASE4","title":"Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural Counseling","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2010-06","conditions":"Smoking Cessation, Psychiatric Illness","enrollment":738},{"nctId":"NCT00063323","phase":"PHASE3","title":"Maintenance Treatment for Abstinent Smokers","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2000-08","conditions":"Tobacco Use Disorder","enrollment":589},{"nctId":"NCT00115687","phase":"PHASE2","title":"Nicotine Replacement Treatment for Pregnant Smokers - 1","status":"TERMINATED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2002-06","conditions":"Tobacco Use Disorder","enrollment":250},{"nctId":"NCT00307203","phase":"PHASE4","title":"Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"1998-08","conditions":"Tobacco-Use Disorder, Schizophrenia, Psychotic Disorders","enrollment":51},{"nctId":"NCT00158171","phase":"PHASE2","title":"Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2002-04","conditions":"Smoking Cessation, Tobacco Use Disorder","enrollment":128},{"nctId":"NCT01087905","phase":"PHASE4","title":"Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2010-04","conditions":"Smoking, Smoking Cessation","enrollment":987},{"nctId":"NCT00320697","phase":"PHASE4","title":"Smoking Relapse Prevention in Schizophrenia","status":"COMPLETED","sponsor":"North Suffolk Mental Health Association","startDate":"2006-04","conditions":"Schizophrenia, Schizoaffective Disorder, Smokers","enrollment":25},{"nctId":"NCT00933595","phase":"NA","title":"Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2007-09","conditions":"Pulmonary Complications, HIV Infections","enrollment":""},{"nctId":"NCT01925781","phase":"PHASE4","title":"e-Cigarettes Versus NRT Gum for Smoking Cessation","status":"TERMINATED","sponsor":"Creighton University","startDate":"2013-08","conditions":"Nicotine Addiction, Smoking Cessation","enrollment":10},{"nctId":"NCT01122238","phase":"PHASE4","title":"Identifying Treatments to Motivate Smokers to Quit","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2010-06","conditions":"Smoking, Smoking Cessation, Motivation","enrollment":517},{"nctId":"NCT01800019","phase":"PHASE3","title":"The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers","status":"UNKNOWN","sponsor":"Ottawa Hospital Research Institute","startDate":"2014-01","conditions":"HIV, Smoking Cessation","enrollment":256},{"nctId":"NCT01120704","phase":"PHASE4","title":"Evaluation of Treatments to Improve Smoking Cessation Medication Adherence","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2010-06","conditions":"Smoking, Smoking Cessation, Adherence","enrollment":544},{"nctId":"NCT01116986","phase":"PHASE4","title":"Identifying Optimal Smoking Cessation Intervention Components (Cessation)","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2010-06","conditions":"Smoking, Smoking Cessation, Nicotine Dependence","enrollment":637},{"nctId":"NCT00119821","phase":"NA","title":"Strategies to Reduce Weight Gain in Hypertensive Smokers","status":"COMPLETED","sponsor":"University of Tennessee","startDate":"2004-09","conditions":"Cardiovascular Diseases, Heart Diseases, Hypertension","enrollment":459},{"nctId":"NCT01990079","phase":"NA","title":"Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD","status":"COMPLETED","sponsor":"Duke University","startDate":"2013-12","conditions":"PTSD, Smoking","enrollment":15},{"nctId":"NCT01328431","phase":"NA","title":"Treating Low-Income Smokers in the Hospital Emergency Department","status":"COMPLETED","sponsor":"Yale University","startDate":"2010-10","conditions":"Tobacco Use Cessation, Smoking Cessation, Smoking","enrollment":780},{"nctId":"NCT00224419","phase":"PHASE4","title":"Testing Pharmacological Therapies for Pregnant Smokers","status":"TERMINATED","sponsor":"Duke University","startDate":"2003-06","conditions":"Smoking, Pregnancy","enrollment":181},{"nctId":"NCT00108342","phase":"NA","title":"Nicotine Delivery Systems: Research & Treatment","status":"TERMINATED","sponsor":"US Department of Veterans Affairs","startDate":"2007-10","conditions":"Smoking","enrollment":25},{"nctId":"NCT01847443","phase":"PHASE1","title":"Comparison of Pharmacokinetic Profiles of Two Nicotine Gum Formulations","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-05","conditions":"Smoking Cessation","enrollment":84},{"nctId":"NCT01465074","phase":"NA","title":"Effects of Acute Nicotine Treatment on Neuroplasticity and Memory in Patients With Schizophrenia","status":"TERMINATED","sponsor":"Centre for Addiction and Mental Health","startDate":"2011-11","conditions":"Schizophrenia","enrollment":20},{"nctId":"NCT01323491","phase":"","title":"\"EASY EFFECTIVE SMOKELESS\" With NICORETTE®","status":"COMPLETED","sponsor":"Johnson & Johnson GmbH","startDate":"2011-04","conditions":"Stereotyped Behavior, Tobacco Smoking Behavior","enrollment":184},{"nctId":"NCT01084707","phase":"NA","title":"Multiple-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product.","status":"COMPLETED","sponsor":"McNeil AB","startDate":"2009-01","conditions":"Tobacco Dependence","enrollment":40},{"nctId":"NCT00749463","phase":"PHASE4","title":"Evaluation of the Safety Profile, Quit and Reduction Rate After Nicorette® Gum and Patch Treatment","status":"COMPLETED","sponsor":"McNeil AB","startDate":"2009-02","conditions":"Tobacco Dependence","enrollment":300},{"nctId":"NCT01084603","phase":"NA","title":"Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product","status":"COMPLETED","sponsor":"McNeil AB","startDate":"2009-03","conditions":"Tobacco Dependence","enrollment":45},{"nctId":"NCT01440985","phase":"NA","title":"A Study on the Effects of Two Nicotine Replacement Products on Tooth Staining","status":"COMPLETED","sponsor":"McNeil AB","startDate":"2005-07","conditions":"Tobacco Dependence","enrollment":200},{"nctId":"NCT01152749","phase":"NA","title":"Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® Gum","status":"COMPLETED","sponsor":"McNeil AB","startDate":"2009-12","conditions":"Tobacco Dependence","enrollment":76},{"nctId":"NCT01152736","phase":"NA","title":"Pharmacokinetics With a New Oral Nicotine Replacement Product and Nicorette® Gum","status":"COMPLETED","sponsor":"McNeil AB","startDate":"2008-11","conditions":"Tobacco Dependence","enrollment":19},{"nctId":"NCT01113424","phase":"NA","title":"Bioequivalence Between Nicotine Replacement Products and Nicorette® Gum","status":"COMPLETED","sponsor":"McNeil AB","startDate":"2008-09","conditions":"Tobacco Dependence","enrollment":88},{"nctId":"NCT01152723","phase":"NA","title":"Pharmacokinetics With Two New Oral Nicotine Replacement Products and Nicorette® Gum","status":"COMPLETED","sponsor":"McNeil AB","startDate":"2008-03","conditions":"Tobacco Dependence","enrollment":28},{"nctId":"NCT00174499","phase":"PHASE4","title":"A Pilot Drug Trial That Evaluates the Whitening Potential of Nicotine Gum","status":"COMPLETED","sponsor":"McNeil AB","startDate":"2005-07","conditions":"Dental Pellicle","enrollment":78},{"nctId":"NCT01234792","phase":"NA","title":"Single-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products. A Study in Healthy Smokers.","status":"COMPLETED","sponsor":"McNeil AB","startDate":"2008-05","conditions":"Tobacco Dependence","enrollment":24},{"nctId":"NCT01234896","phase":"NA","title":"Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement Products","status":"COMPLETED","sponsor":"McNeil AB","startDate":"2010-10","conditions":"Tobacco Dependence","enrollment":44},{"nctId":"NCT01228617","phase":"NA","title":"Single-dose Pharmacokinetics of Oral Nicotine Replacement Products","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer and Personal Products Worldwide","startDate":"2007-09","conditions":"Tobacco Dependence","enrollment":40},{"nctId":"NCT01333202","phase":"NA","title":"Fresh Lime Alone for Smoking Cessation","status":"COMPLETED","sponsor":"Thai Health Professional Alliance Against Tobacco","startDate":"2009-03","conditions":"Tobacco Use Disorder","enrollment":100},{"nctId":"NCT01182129","phase":"PHASE1, PHASE2","title":"4 mg Nicotine Polacrilex Gum and Swedish Portion Snus","status":"COMPLETED","sponsor":"Contract Research Organization el AB","startDate":"2006-03","conditions":"Healthy Subjects, Smokers","enrollment":15},{"nctId":"NCT01104896","phase":"PHASE4","title":"Effect of Daily Nicotine Patch Application on Mechanical Ventilation Weaning in Smoking Patients","status":"UNKNOWN","sponsor":"University of Paris 5 - Rene Descartes","startDate":"2010-01","conditions":"Smoking, Mechanical Ventilation, Intensive Care","enrollment":600},{"nctId":"NCT00977249","phase":"PHASE2, PHASE3","title":"Varenicline for Long-term Nicotine Replacement Therapy (NRT) Users","status":"UNKNOWN","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2009-09","conditions":"Tobacco Dependence","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"20170414","type":"SUPPL","sponsor":"P AND L","applicationNumber":"ANDA078699"},{"date":"20150430","type":"SUPPL","sponsor":"P AND L","applicationNumber":"ANDA078699"},{"date":"20081229","type":"ORIG","sponsor":"P AND L","applicationNumber":"ANDA078699"},{"date":"20130128","type":"SUPPL","sponsor":"P AND L","applicationNumber":"ANDA078699"},{"date":"20150430","type":"SUPPL","sponsor":"P AND L","applicationNumber":"ANDA079044"},{"date":"20090708","type":"ORIG","sponsor":"P AND L","applicationNumber":"ANDA079044"},{"date":"20130128","type":"SUPPL","sponsor":"P AND L","applicationNumber":"ANDA079044"},{"date":"20170412","type":"SUPPL","sponsor":"P AND L","applicationNumber":"ANDA079044"}],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Nicotine Polacrilex Gum (2 mg)","genericName":"Nicotine Polacrilex Gum (2 mg)","companyName":"University of Hawaii","companyId":"university-of-hawaii","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nicotine binds to nicotinic acetylcholine receptors in the brain to reduce cravings and withdrawal symptoms during smoking cessation. Used for Smoking cessation aid.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}